Agathos Biologics launches as a cell and gene therapy company

By The Science Advisory Board staff writers

April 21, 2021 -- Agathos Biologics has launched as a cell and gene therapy research and development company in Fargo, ND.

The company will focus on developing science in biomanufacturing, biologic payload delivery, and cell and gene therapies. Entrepreneurs James Brown, Michael Chambers, and John Ballantyne have funded the company, which aims to develop and manufacture therapies ethically.

Copyright © 2021

CPhI North America
August 10-12
Philadelphia, Pennsylvania United States
Bioprocessing Summit
August 16-19
Boston, Massachusetts United States
6th Annual CAR-TCR Summit
August 30 - September 2
European Congress of Immunology (ECI) 2021
September 1-4
Belgrade Serbia
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter